Receptors: potential medications development target for anti-cocaine agents

Author： Matsumoto R.R.   Liu Y.   Lerner M.   Howard E.W.   Brackett D.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.469, Iss.1, 2003-05, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine transporter as target for drug development of cocaine dependence medications

By Dutta A.K.   Zhang S.   Kolhatkar R.   Reith M.E.A.  

European Journal of Pharmacology, Vol. 479, Iss. 1, 2003-10 ,pp. : 93-106

Elsevier

Access to resources Recommend Favorite

Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting 1 receptors produce anti-cocaine effects in mice

By Matsumoto R.R.   McCracken K.A.   Friedman M.J.   Pouw B.   De Costa B.R.   Bowen W.D.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 163-174

Elsevier

Access to resources Recommend Favorite

Anti-cocaine vaccines: antibody protection against relapse

By Kantak Kathleen M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 2, 2003-02 ,pp. : 213-218

Informa Healthcare

Access to resources Recommend Favorite

Collagen Receptors as Potential Targets for Novel Anti-Platelet Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-01 ,pp. : 2673-2683

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cocaine Vaccine Based on Coupling a Cocaine Analog to a Disrupted Adenovirus

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 8, 2011-12 ,pp. : 899-904

Bentham Science Publishers

Access to resources Recommend Favorite